Description
Trauma resuscitation startup developing NKA01, an anti-shock injection, under an Air Force SBIR Phase II for combat casualty care.
Why It Belongs Here
No specific defense relevance signals have been verified yet.
Details
Links
Domain: nkabio.com
Sources and Evidence
Evidence Links
No evidence links have been extracted yet.